alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
**
**Exhibit 31.2**

**Certification of Chief Financial Officer Pursuant to**

**Section 302 of the Sarbanes-Oxley Act of 2002**

I, Brian McCourt, certify that: 

 
1.
I have reviewed this Annual Report on Form 10-K/A of Bogota FinancialCorp.; 

 
2.
Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state amaterial fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report; 

 
3.
Based on my knowledge, the financial statements, and other financial information included in this report,fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report; 

 
4.
I am responsible for establishing and maintaining disclosure controls and procedures (as defined in ExchangeAct Rules 13a-15(e) and 15d-15(e)) for the registrant and have: 

 
 a)
Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to bedesigned under my supervision, to ensure that material information relating to the registrant is made known to me by others within the entity, particularly during the period in which this report is being prepared; 

 
 b)
Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in thisreport our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and 

 
 c)
Disclosed in this report any change in the registrant’s internal control over financial reporting thatoccurred during the registrant’s most recent fiscal quarter that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and 

 
5.
I have disclosed, based on my most recent evaluation of internal control over financial reporting, to theregistrant’s auditors and the audit committee of the registrant’s board of directors: 

 
 a)
All significant deficiencies and material weaknesses in the design or operation of internal control overfinancial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and 

 
 b)
Any fraud, whether or not material, that involves management or other employees who have a significant role inthe registrant’s internal control over financial reporting. 

 
  Date: April 29, 2020   
/s/ Brian McCourt
   Brian McCourt   Chief Financial Officer**
Exhibit 32

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350,

AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

The
undersigned, the Chief Executive Officer and the Vice President and Cashier of Communitycorp (the Company), each certify that, to his or her knowledge on the date of this certification:



| | 1. | The quarterly report of the Company for the period ended September 30, 2008 as filed with the Securities and Exchange Commission on this date (the Report) fully
complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and
| | -- | -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------



| | 2. | The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company.
| | -- | ---------------------------------------------------------------------------------------------------------------------------------------------------



|                        |  |     |  |                                      
|----------------------- |  | --- |  | -------------------------------------
|Date: November 12, 2008 |  | By: |  | /s/ W. Roger Crook                   
|                        |  |     |  | W. Roger Crook                       
|                        |  |     |  | President and Chief Executive Officer
|                        |  |    
|Date: November 12, 2008 |  | By: |  | /s/ Gwendolyn P. Bunton              
|                        |  |     |  | Gwendolyn P. Bunton                  
|                        |  |     |  | Vice President and Cashier
#### Beol, Inc., in Behalf of Itself and Other Judgment Creditors Similarly Situated, Respondent, v. Herman S. Dorf et al., Appellants, et al., Defendants.

Judgment and order unanimously affirmed, with costs to the respondent. No opinion. Concur — Botein, P. J., Rabin, Valente, McNally and Eager, JJ.
Need to return call by / at/between and

. Signature: Project No.: 0172.08.005.60 3 Page 1 of 1

Project Name: DMR2009 

### CBI?

Yes

No TELEPHONE CALL RECOR D

Incoming

Outgoing Date: 0 2/24/11 Time: 10:24 am

pm

Company Name: Seapac of Idaho, Inc. ERG Staff Name: Kimberly Landick

Contact Name: Tom VanTassel Contact Phone Number: ( 208) 837

- 6541

General Subject: 2009 DMR Copper Discharges



### TOPICS DISCUSSED AND ACTION TAKEN

On February 24, 2011 at 10:24am I called the Water Quality Division of the Idaho Department of

Environmental Quality (208

- 373

- 0120). I was told to call the Twin Falls Regional Office of the DEQ (208

- 736

- 2190). I called this office and spoke with Pat Hayes. She told me that I need to submit a Public Records Request

and include the details of the facilities and a timeframe of request. To submit a Public Records Request go to

www.deq.idaho.gov , click on Find it Fast, Publ ic Records Request, Online Request. The online request did not

work for me so I was told to fax over a request to 208

- 373

- 0417.

On March 1, 2011 at 4:14pm I called the facility directly using the PCS contact from OTIS (Tom VanTassel

208

- 837

- 6541) and lef t a message. At 5:08pm Mr. VanTassel returned my call and left a message.

On March 2, 2011 at 9:29am I called Mr. VanTassel back. He told me that they have seven outfalls and they

compile all the samples into one composite sample to send to the lab. It’s also a two

- tiered hatchery. They have

ten different raise ways and they apply copper to each at 20 minute intervals. He confirmed the values below:

Copper Concentrations: 20090331 18.3 UGL

20090630 32.6 UGL

Flow: 20090331 92.22 CFS (measure on a weekly basis)

We had MGL for concentration values. Recommend changing milligrams per liter to micrograms per liter for

all 2009 copper concentrations.
Exhibit 32.1

CERTIFICATION

Pursuant to the requirement set forth
in Rule 13a-14(b) of the Securities Exchange Act of 1934, as amended, (the Exchange Act) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. §1350), Claes Glassell, the Chief Executive
Officer of Cerus Corporation (the Company) and Kevin D. Green, the Vice President, Finance and Chief Accounting Officer of the Company, hereby certify that, to the best of their knowledge:

1. The Companys Quarterly Report on Form 10-Q for the period ended September 30, 2009, and to which this
Certification is attached as Exhibit 32.1 (the Periodic Report), fully complies with the requirements of section 13(a) or section 15(d) of the Exchange Act, and

2. The information contained in the Periodic Report fairly presents, in all material respects, the financial condition and results of
operations of the Company.

IN WITNESS WHEREOF, the undersigned have set their hands hereto as of the 6th day of November,
2009.



/s/ Claes GlassellClaes GlassellChief Executive Officer(Principal Executive Officer)/s/ Kevin D. GreenKevin D. GreenVice President, Finance and Chief Accounting Officer (Principal Financial Officer)
TREATIES AND OTHER INTERNATIONAL ACTS SERIES 19-613

________________________________________________________________________

LAW ENFORCEMENT

Extradition

Treaty Between the

UNITED STATES OF AMERICA

and KOSOVO

Signed at Pristina March 29, 2016
NOTE BY THE DEPARTMENT OF STATE

Pursuant to Public Law 89—497, approved July 8, 1966

(80 Stat. 271; 1 U.S.C. 113)—

“. . .the Treaties and Other International Acts Series issued

under the authority of the Secretary of State shall be competent

evidence . . . of the treaties, international agreements other than

treaties, and proclamations by the President of such treaties and

international agreements other than treaties, as the case may be, 

therein contained, in all the courts of law and equity and of maritime

jurisdiction, and in all the tribunals and public offices of the

United States, and of the several States, without any further proof

or authentication thereof.”
KOSOVO

Law Enforcement: Extradition

Treaty signed at Pristina March 29, 2016.

Transmitted by the President of the United States of America

to the Senate January 17, 2017 (Treaty Doc. 115-2,

115th Congress, 1st Session).

Reported favorably by the Senate Committee on Foreign Relations

March 20, 2018 (Senate Executive Report No. 115-5,

115th Congress, 2d Session).

Advice and consent to ratification by the Senate July 26, 2018.

Ratified by the President December 20, 2018.

Ratified by Kosovo April 4, 2016.

Exchange of instruments of ratification at Pristina

June 13, 2019.

Entered into force June 13, 2019.
#### Nathan Stambler, Doing Business as Breuckelen Guild, Respondent, v. Rite-Glo, Inc., Appellant.

No opinion. Present — Nolan, P. J., Carswell, Sneed, Wenzel and MacCrate, JJ.
### §274f–4. Report relating to organ donation and the recovery, preservation, and transportation of organs

#### (a) In general

Not later than December 31, 2005, and every 2 years thereafter, the Secretary shall report to the appropriate committees of Congress on the activities of the Department carried out pursuant to this part, including an evaluation describing the extent to which the activities have affected the rate of organ donation and recovery.

#### (b) Requirements

To the extent practicable, each report submitted under subsection (a) shall—

(1) evaluate the effectiveness of activities, identify effective activities, and disseminate such findings with respect to organ donation and recovery;

(2) assess organ donation and recovery activities that are recently completed, ongoing, or planned; and

(3) evaluate progress on the implementation of the plan required under subsection (c)(5).

#### (c) Initial report requirements

The initial report under subsection (a) shall include the following:

(1) An evaluation of the organ donation practices of organ procurement organizations, States, other countries, and other appropriate organizations including an examination across all populations, including those with low organ donation rates, of—

(A) existing barriers to organ donation; and

(B) the most effective donation and recovery practices.

(2) An evaluation of living donation practices and procedures. Such evaluation shall include an assessment of issues relating to informed consent and the health risks associated with living donation (including possible reduction of long-term effects).

(3) An evaluation of—

(A) federally supported or conducted organ donation efforts and policies, as well as federally supported or conducted basic, clinical, and health services research (including research on preservation techniques and organ rejection and compatibility); and

(B) the coordination of such efforts across relevant agencies within the Department and throughout the Federal Government.

(4) An evaluation of the costs and benefits of State donor registries, including the status of existing State donor registries, the effect of State donor registries on organ donation rates, issues relating to consent, and recommendations regarding improving the effectiveness of State donor registries in increasing overall organ donation rates.

(5) A plan to improve federally supported or conducted organ donation and recovery activities, including, when appropriate, the establishment of baselines and benchmarks to measure overall outcomes of these programs. Such plan shall provide for the ongoing coordination of federally supported or conducted organ donation and research activities.

(July 1, 1944, ch. 373, title III, §377D, as added Pub. L. 108–216, §6, Apr. 5, 2004, 118 Stat. 588.)
Exhibit 23


CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM


We consent to the incorporation by reference in the following Registration Statements:


(1) Registration Statement (Form S-3 No. 333-264693) and in the related Prospectuses of The Clorox Company, and





(2) Registration Statements (Form S-8 Nos. 33-56563, 33-56565, 33-41131, including post effective amendments No. 1 and No. 2, 333-16969, 333-29375, 333-44675, 333-69455, including post effective amendment No. 1, 333-86783, 333-90386, including the post effective amendment No. 1, 333-131487, 333-193913 and 333-213161) of The Clorox Company;


of our reports dated August 10, 2023, with respect to the consolidated financial statements of The Clorox Company and the effectiveness of internal control over financial reporting of The Clorox Company included in this Annual Report (Form 10-K) of The Clorox Company for the year ended June 30, 2023.


/s/ Ernst & Young LLP


San Francisco, CA


August 10, 2023
**Exhibit 32.2**

**CERTIFICATIONPURSUANT TO18 U.S.C. SECTION 1350,AS ADOPTED PURSUANT TOSECTION 906 OF THE SARBANES-OXLEY ACT OF 2002**

In connection withthe Quarterly Report of Monster Worldwide, Inc. (the “Company”) on Form 10-Qfor the quarter ended June 30, 2005 as filed with the Securities andExchange Commission on the date hereof (the “Report”), I, Charles Baker, ChiefFinancial Officer of the Company, certify, pursuant to 18 U.S.C. § 1350, asadopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:

(1)   TheReport fully complies with the requirements of Section 13(a) or 15(d) ofthe Securities Exchange Act of 1934; and

(2)   Theinformation contained in the Report fairly presents, in all material respects,the financial condition and result of operations of the Company.
|        |   | By:    |   | /s/ CHARLES  BAKER                                         |   |   |
|--------|--------|--------|--------|------------------------------------------------------------|--------|--------|
|   |   |   |   | Charles Baker  Chief Financial Officer  August 8 2005 |   |   |

 

A signed original of this written statement required by Section 906,or other document authenticating, acknowledging, or otherwise adopting thesignature that appears in typed form within the electronic version of thiswritten statement required by Section 906, has been provided to MonsterWorldwide, Inc. and will be retained by Monster Worldwide, Inc. andfurnished to the Securities and Exchange Commission or its staff upon request.

----
**Exhibit 10.5**

 

**NAME OF EMPLOYEE**

**ADDRESS OF EMPLOYEE**

 

 

**8 June 2005**

 

**Dear Colleague**

 

**SHAREOPTIONS STATEMENT**

 

This statement details your lastminute.complc (“lastminute.com”) shares under option and should be read in conjunctionwith the accompanying letters (“the Letters”) regarding the RecommendedAcquisition of lastminute.com by Travelocity Europe Limited, a wholly ownedsubsidiary of Sabre, Inc., the terms and conditions enclosed with theLetters and the Scheme Document.

 

**Statementre Share Options**

 
| **Option  Scheme  Name** | ** ** | **Option Grant  Date** | ** ** | **Option price  (pence)** | ** ** | **Number of lastminute.com shares  under option** |
|--------------------------|------------|------------------------|------------|---------------------------|------------|---------------------------------------------------|
| ** **               | ** ** | ** **             | ** ** | ** **                | ** ** | ** **                                        |
| ** **               | ** ** | ** **             | ** ** | ** **                | ** ** | ** **                                        |
| ** **               | ** ** | ** **             | ** ** | ** **                | ** ** | ** **                                        |

 

Please read the Letters carefully as youroption(s) will in due course lapse unless you take steps to exercise it/them.

 

If you have any queries please contact theCompany Secretarial Department on + 44 (0)20 7866 4455.

 

 
| Yours sincerely    |
|--------------------|
|               |
| /s/ Simon Watkins  |   |
| **Simon  Watkins** |
| Company Secretary  |

 

1

----
Exhibit 32.1


CERTIFICATION PURSUANT TO


18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO


SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002








In connection with the Annual Report of Arcutis Biotherapeutics, Inc. (the “Company”) on Form 10-K for the year ending December 31, 2019 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Todd Franklin Watanabe, President, Chief Executive Officer and Director of the Company, and John W. Smither, Chief Financial Officer of the Company, do each hereby certify, pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley Act of 2002, that:





(1) The Report fully complies with the requirements of section 13(a) or 15(d) of the Securities Exchange Act of 1934; and


(2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company for the period covered by the Report.














Date: March 19, 2020By:/s/ Todd Franklin WatanabeTodd Franklin WatanabePresident, Chief Executive Officer and Director(Principal Executive Officer)Date: March 19, 2020By:/s/ John W. SmitherJohn W. SmitherChief Financial Officer(Principal Accounting and Financial Officer)
_________________________________________ 

 

 

Order Michigan Supreme Court 

Lansing, Michigan 

December 27, 2005 Clifford W. Taylor,

 Chief Justice 

Michael F. Cavanagh 

Elizabeth A. Weaver 129170 

Marilyn Kelly 

Maura D. Corrigan 

Robert P. Young, Jr. 

Stephen J. Markman, PEOPLE OF THE STATE OF MICHIGAN, Justices 

Plaintiff-Appellee, 

v SC: 129170 

 COA: 252555 

Oakland CC: 03-188990-FH 

DUSTIN ALAN CARLETON, 

Defendant-Appellant. 

_________________________________________/ 

On order of the Court, the application for leave to appeal the June 21, 2005 

judgment of the Court of Appeals is considered, and it is DENIED, because we are not 

persuaded that the questions presented should be reviewed by this Court. 

d1219 

I, Corbin R. Davis, Clerk of the Michigan Supreme Court, certify that the 

foregoing is a true and complete copy of the order entered at the direction of the Court. 

December 27, 2005 

Clerk
#### § 1411.1 Purpose and scope.

This part contains the regulations of the Foreign Service Labor Relations Board (the Board), the General Counsel of the Federal Labor Relations Authority (the General Counsel) and the Foreign Service Impasse Disputes Panel (the Panel) providing for public access to information from the Board, the General Counsel or the Panel. These regulations implement the Freedom of Information Act, as amended, 5 U.S.C. 552, and the policy of the Board, the General Counsel and the Panel to disseminate information on matters of interest to the public and to disclose to members of the public on request such information contained in records insofar as is compatible with the discharge of their responsibilities, consistent with applicable law.
#### The People of the State of New York, Respondent, v Joseph Johnson, Appellant.

[820 NYS2d 272]

Judgment, Supreme Court, New York County (Edward J. McLaughlin, J.), rendered March 10, 2003, convicting defendant, after a jury trial, of robbery in the first and second degrees, and sentencing him to concurrent terms of 15 years, unanimously affirmed.

The court properly denied defendant’s challenge for cause to a prospective juror, since the totality of her responses established that she would be fair and impartial *(see People v Arnold,*96 NY2d 358, 362 [2001]). Although she voiced some hesitation at one point, the panelist was completely rehabilitated when, in the same colloquy, she gave the court her unequivocal assurance that she could be fair *(see e.g. People v Knight,*29 AD3d 306 [2006]).

Defendant’s remaining claim is without merit. The record establishes that the jury’s verdict was unanimous with respect to each of the counts upon which defendant was convicted. *372Concur — Tom, J.E, Friedman, Sullivan, Catterson and Malone, JJ.
Need to return call by / at/between and . Signature: ___________________________ 

Project No.: 0172.07.005.504 DISTRIBUTION 

Page _1_ of __1_

Project Name: 304(m) Annual Review 

TELEPHONE CALL RECORD 

 Outgoing Call 

Date: 3/17/2010 Time: 10:30 am EST 

Company Name: Former Koppers 

 (MO0120294) 

Contact Name: Dave Rayna 

Phone No.: 412-208-0413 

Name: Elizabeth Sabol Eastern Research Group 

GENERAL SUBJECT : TCDD concentrations reported to DMR in 2008 

 

TOPICS DISCUSSED AND ACTION TAKEN 

I called Former Koppers Facility on March 17, 2010, to speak with Robert Fisher (412-208-8860), on March 17, 

2010. Mr. Fisher forwarded my information to Dave Rayna who called me back later that day. I explained to 

Mr. Rayna who I was and why I was calling; we briefly discussed the Former Koppers Facility and TCDD 

concentrations reported to DMR in 2008. 

Mr. Rayna explained that the facility is no longer in operation, and that the only thing that remains is the land.

He stated that they only monitor the two storm water discharges at the site (Outfalls 004 and 005). Mr. Rayna 

explained that the TCDD concentrations are almost always non-detect. He stated that he would look through all 

of the monthly reports to confirm all non-detect measurements for 2008. At about 3:30 pm, Mr. Rayna called 

me back confirming that all TCDD concentrations were reported below the detection limit in 2008 for Outfalls 

004 and 005. BDL indicators should be added to the 2008 TCDD concentrations.
##### 



Exhibit 32.1

CERTIFICATION PURSUANT TO
18 U.S.C. SECTION 1350,
AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Kroll Inc. (the Company) on
Form 10-Q for the period ended September 30, 2003 as filed with the Securities
and Exchange Commission on the date hereof (the Report), I, Michael G.
Cherkasky, Chief Executive Officer of the Company, certify, pursuant to 18
U.S.C. (S) 1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of 2002,
that:



| | 1. |  | The Report fully complies with the requirements of section
13(a) or 15(d) of the Securities Exchange Act of 1934; and                               
| | -- |  | ----------------------------------------------------------------------------------------------------------------------------------------------------
|
| | 2. |  | The information contained in the Report fairly presents, in all
material respects, the financial condition and results of operations
of the Company.

/s/ Michael G. CherkaskyMichael G. Cherkasky
Chief Executive Officer
November 14, 2003

42